BRAIN COMMUNICATIONS, 2024 · DOI: https://doi.org/10.1093/braincomms/fcae143 · Published: April 20, 2024
This study investigated the relationship between systemic inflammation and the progression of multiple sclerosis (MS), specifically focusing on brain and spinal cord atrophy. Systemic inflammation was measured using urinary neopterin levels, and MRI was used to assess brain and cervical spinal cord atrophy over a 2.5-year period. The study found that systemic inflammation was associated with cervical cord atrophy, suggesting that inflammation outside the central nervous system may contribute to the progression of disability in MS.
Systemic inflammation may be a potential therapeutic target for slowing neurodegeneration in MS.
Urinary neopterin-to-creatinine ratio (UNCR) can be used to monitor systemic inflammation in longitudinal studies.
Further research is needed to prove causation and to explore the underlying biology of the relationship between systemic inflammation and MS progression.